AT140620T - Glasartige kohlenhydratenmatrize zur verabreichung von heilmitteln mit verzögerter wirkstoffabgabe - Google Patents

Glasartige kohlenhydratenmatrize zur verabreichung von heilmitteln mit verzögerter wirkstoffabgabe


Publication number
AT140620T AT92925051T AT92925051T AT140620T AT 140620 T AT140620 T AT 140620T AT 92925051 T AT92925051 T AT 92925051T AT 92925051 T AT92925051 T AT 92925051T AT 140620 T AT140620 T AT 140620T
Prior art keywords
Prior art date
Application number
Other languages
English (en)
Siva N Raman
John P Cunningham
Original Assignee
Mallinckrodt Veterinary Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US80258191A priority Critical
Application filed by Mallinckrodt Veterinary Inc filed Critical Mallinckrodt Veterinary Inc
Publication of AT140620T publication Critical patent/AT140620T/de
First worldwide family litigation filed litigation Critical "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.



    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
AT92925051T 1991-12-05 1992-11-02 Glasartige kohlenhydratenmatrize zur verabreichung von heilmitteln mit verzögerter wirkstoffabgabe AT140620T (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US80258191A true 1991-12-05 1991-12-05

Publications (1)

Publication Number Publication Date
AT140620T true AT140620T (de) 1996-08-15



Family Applications (1)

Application Number Title Priority Date Filing Date
AT92925051T AT140620T (de) 1991-12-05 1992-11-02 Glasartige kohlenhydratenmatrize zur verabreichung von heilmitteln mit verzögerter wirkstoffabgabe

Country Status (11)

Country Link
US (1) US5356635A (de)
EP (1) EP0615438B1 (de)
CN (1) CN1065439C (de)
AT (1) AT140620T (de)
AU (1) AU3125193A (de)
CA (1) CA2125148C (de)
DE (2) DE69212497D1 (de)
DK (1) DK0615438T3 (de)
ES (1) ES2090714T3 (de)
TW (1) TW337488B (de)
WO (1) WO1993010758A1 (de)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT264096T (de) 1994-03-07 2004-04-15 Nektar Therapeutics Verfahren und mittel zur verabreichung von insulin über die lunge
US5817327A (en) * 1994-07-27 1998-10-06 The Trustees Of The University Of Pennsylvania Incorporation of biologically active molecules into bioactive glasses
DE69531992D1 (de) * 1994-08-04 2003-11-27 Elan Drug Delivery Ltd Feste verabreichungssysteme zur gesteuerten freisetzung von darin eingebauten molekülen sowie verfahren zu deren herstellung
US6586006B2 (en) * 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
JPH10508744A (ja) 1994-09-22 1998-09-02 クオドラント ホールディングス ケンブリッジ リミテッド 運動競技の間の水分補給および栄養摂取の用途のための組成物ならびにその製造法
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
DE69628007T2 (de) * 1995-06-07 2003-11-27 Elan Drug Delivery Ltd Verfahren zur stabilen einarbeitung von substanzen in trockene geschäumte glasmatrizen und auf diese weise hergestellte zusammensetzungen
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US5958455A (en) * 1996-02-09 1999-09-28 Quadrant Holdings Cambridge Ltd Oral solid dosage forms, methods of making same and compositions thereof
US5762961A (en) * 1996-02-09 1998-06-09 Quadrant Holdings Cambridge Ltd. Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
AU3508097A (en) 1996-06-26 1998-01-14 Board Of Regents, The University Of Texas System Hot-melt extrudable pharmaceutical formulation
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
US6149939A (en) * 1997-05-09 2000-11-21 Strumor; Mathew A. Healthful dissolvable oral tablets, and mini-bars
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6352722B1 (en) 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
US6187330B1 (en) 1998-01-30 2001-02-13 Scios Inc. Controlled release delivery of peptide or protein
KR19990071255A (ko) 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물
US6541021B1 (en) 1999-03-18 2003-04-01 Durect Corporation Devices and methods for pain management
US6835194B2 (en) 1999-03-18 2004-12-28 Durect Corporation Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
DE60003803T2 (de) 1999-04-16 2004-06-03 Novo Nordisk A/S Trockene formbare arzneistoffformulierung
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
US6207193B1 (en) * 1999-12-27 2001-03-27 Stephen E. Feldman Transdermal drug delivery system
WO2001062296A2 (en) 2000-02-24 2001-08-30 Monsanto Technology Llc Non-aqueous injectable formulations for extended release of somatotropin
US7074803B2 (en) * 2001-03-02 2006-07-11 Durect Corporation Opioid formulations
AU4921401A (en) 2000-03-15 2001-09-24 Brigham & Womens Hospital Suppression of vascular disorders by mucosal administration of heat shock protein peptides
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US6719992B2 (en) 2000-06-26 2004-04-13 Monsanto Technology Llc Non-aqueous surfactant-containing formulations for extended release of somatotropin
US6664234B1 (en) 2000-06-30 2003-12-16 Monsanto Technology Llc Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
WO2002005744A1 (en) * 2000-07-14 2002-01-24 Novo Nordisk A/S Method of moulding a pharmaceutical composition in a packaging material
GB0124710D0 (en) * 2001-10-15 2001-12-05 Quadrant Healthcare Uk Ltd Therapeutic composition
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
AT508735T (de) 2001-12-19 2011-05-15 Novartis Ag Pulmonale verabreichung von aminoglykosiden
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
US20040102476A1 (en) * 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
CA2507522C (en) * 2002-12-13 2015-02-24 Durect Corporation Oral drug delivery system
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
EP1781264B1 (de) 2004-08-04 2013-07-24 Evonik Corporation Verfahren zur herstellung von abgabevorrichtungen und damit erhaltene vorrichtungen
US8753665B2 (en) 2004-09-17 2014-06-17 Durect Corporation Controlled delivery system
EP1835933A4 (de) 2005-01-04 2015-01-07 Yeda Res & Dev Hsp60, hsp60-peptide und t-zellen-impfstoffe zur immunmodulation
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
WO2006109312A2 (en) * 2005-04-15 2006-10-19 Vascular Biogenics Ltd. Compositions containing beta 2-glycoprotein i-derived peptides for the prevention and/or treatment of vascular disease
BRPI0613731A2 (pt) 2005-07-12 2011-02-01 Renovo Ltd composição farmacêutica, recipiente enchido previamente, bem como uso de um açúcar para aprimorar a recuperação e/ou aumentar a atividade biológica de um membro da superfamìlia tgf-beta
GB2430880A (en) * 2005-10-04 2007-04-11 Cambridge Biostability Ltd Pharmaceutical compositions stabilized in glassy particles
SA2709B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
ITMI20061692A1 (it) 2006-09-05 2008-03-06 Alfa Wassermann Spa Uso di polioli per ottenere forme polimorfe stabili di rifaximina
US8337883B2 (en) 2006-11-03 2012-12-25 Durect Corporation Transdermal delivery systems
US8415401B2 (en) 2007-12-06 2013-04-09 Durect Corporation Oral pharmaceutical dosage forms
ES2718612T3 (es) 2007-12-20 2019-07-03 Evonik Corp Procedimiento para preparar micropartículas que tienen un bajo volumen de disolvente residual
KR101616246B1 (ko) 2008-01-25 2016-05-02 그뤼넨탈 게엠베하 약제학적 투여형
WO2009111649A2 (en) 2008-03-05 2009-09-11 Regenerative Research Foundation Methods and compositions for delivery of exogenous factors to nervous system sites
EP2273983B1 (de) 2008-05-09 2016-07-20 Grünenthal GmbH Verfahren für die zubereitung eines pulverförmigen zwischenprodukts und einer endgültigen festen darreichungsform anhand eines sprüherstarrungsschrittes
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
JP2012533585A (ja) 2009-07-22 2012-12-27 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 酸化感受性オピオイドのための不正使用防止剤形
MX2012000317A (es) 2009-07-22 2012-02-08 Gruenenthal Gmbh Forma de dosificacion de liberacion controlada extruida por fusion en caliente.
EP2805965A1 (de) 2009-12-21 2014-11-26 Ambrx, Inc. Modifizierte Schweine-Somatotropin-Polypeptide und deren Verwendungen
EP2805964A1 (de) 2009-12-21 2014-11-26 Ambrx, Inc. Modifizierte Rinder-Somatotropinpolypeptide und deren Verwendungen
JP6660080B2 (ja) 2010-07-01 2020-03-04 リジェネレイティブ リサーチ ファウンデーション 持続放出組成物を用いる未分化細胞培養方法
KR20130137627A (ko) 2010-09-02 2013-12-17 그뤼넨탈 게엠베하 음이온성 중합체를 포함하는 내변조성 투여형
MX348491B (es) 2011-07-29 2017-06-15 Grünenthal GmbH Tableta a prueba de manipulacion que proporciona liberacion inmediata de fármaco.
US20130225697A1 (en) 2012-02-28 2013-08-29 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
PT2838512T (pt) 2012-04-18 2018-11-09 Gruenenthal Gmbh Forma farmacêutica resistente à adulteração e resistente à libertação inesperada de alta quantidade (dose-dumping)
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
CA2905131A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
BR112015026549A2 (pt) 2013-05-29 2017-07-25 Gruenenthal Gmbh forma de dosagem à prova de violação contendo uma ou mais partículas
JP6466417B2 (ja) 2013-05-29 2019-02-06 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 二峰性放出プロファイルを有する改変防止(tamper−resistant)剤形
BR112016000194A8 (pt) 2013-07-12 2019-12-31 Gruenenthal Gmbh forma de dosagem resistente à violação contendo o polímero de acetato de etileno-vinila
CA2931553A1 (en) 2013-11-26 2015-06-04 Grunenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling
US20150320690A1 (en) 2014-05-12 2015-11-12 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
AU2015266117A1 (en) 2014-05-26 2016-11-24 Grunenthal Gmbh Multiparticles safeguarded against ethanolic dose-dumping
US20180325819A1 (en) * 2014-11-21 2018-11-15 Technical University Of Denmark Gel formulations for local drug release
US20160310429A1 (en) 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
US20170071982A1 (en) * 2015-09-16 2017-03-16 Immune Ventures LLC In vivo priming of natural killer cells

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2413419A (en) * 1943-02-27 1946-12-31 Searle & Co Pellet for administering gonadotropic pituitary hormones
US2918411A (en) * 1957-11-01 1959-12-22 Olin Mathieson Pharmaceutical preparations
FR2383659B1 (de) * 1977-03-16 1983-02-25 Berri Balzac
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
US5266333A (en) * 1985-03-06 1993-11-30 American Cyanamid Company Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US4671953A (en) * 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics
US4765980A (en) * 1986-04-28 1988-08-23 International Minerals & Chemical Corp. Stabilized porcine growth hormone
US4857506A (en) * 1987-01-12 1989-08-15 American Cyanamid Company Sustained release growth hormone compositions for parenteral administration and their use
JP2821925B2 (ja) * 1987-11-16 1998-11-05 バクスター、インターナショナル、インコーポレイテッド 有益な剤の制御された投与のためのガラス状マトリックス
EP0345628B1 (de) * 1988-06-07 1993-05-12 Abbott Laboratories Feste Arzneidosis in Form eines Tablettentriturats sowie Verfahren zu deren Herstellung
US5219572A (en) * 1989-03-17 1993-06-15 Pitman-Moore, Inc. Controlled release delivery device for macromolecular proteins

Also Published As

Publication number Publication date
ES2090714T3 (es) 1996-10-16
US5356635A (en) 1994-10-18
DE69212497D1 (de) 1996-08-29
CN1072861A (zh) 1993-06-09
EP0615438B1 (de) 1996-07-24
WO1993010758A1 (en) 1993-06-10
AU3125193A (en) 1993-06-28
DE69212497T2 (de) 1996-12-12
TW337488B (en) 1998-08-01
DK615438T3 (de)
CA2125148C (en) 1999-05-11
CA2125148A1 (en) 1993-06-10
DK0615438T3 (da) 1996-11-11
EP0615438A1 (de) 1994-09-21
CN1065439C (zh) 2001-05-09

Similar Documents

Publication Publication Date Title
US5525634B1 (en) Colonic drug delivery system
FI99081B (fi) Oraaliseen, lääkkeen viivästettyyn antoon nisäkkäälle tarkoitettu lääkkeenantoväline
DE68902344T2 (de) Arzneimittel mit guter stabilitaet.
DK0573576T3 (da) Midler til topisk administration af farmaceutisk aktive stoffer
DE69318415T2 (de) Arzneitablette, die befähigt ist, einen oder mehrere wirkstoffe mit unterschiedlichen abgaberaten freizusetzen
DE69227187T2 (de) Arzneistoffabgabesysteme mit verzögerter freisetzung
DK0531497T3 (da) Orale indgivelsessystemer til mikropartikler
DE68908456T2 (de) Matrix zur Wirkstoffabgabe.
DE68929153T2 (de) Gerät zum Verabreichen von Medikamenten
DE69423342D1 (de) Transmukosale verabreichung von makromolekularen medikamenten
DE3751121T2 (de) Gerät zur transkutanen Verabreichung von Heilmitteln.
DE58904179D1 (de) Septum fuer implantierbare vorrichtungen zur abgabe von wirkstoffen.
DE69323739D1 (de) Arzneimittel infusionsvorrichtung
DE69224619D1 (de) Arzneimittelausgabesystem
DE69101314T2 (de) Dosierungsform zur verabreichung eines arzneimittels an die därme.
DE3263209D1 (en) Drug administration device
DE3880593D1 (de) Arzneizubereitungen mit retardierter wirkstofffreisetzung.
IE49615B1 (en) Pharmaceutical preparations for the parenteral administration of fat-soluble active substances
AU6519390A (en) Interactive patient assistance and medication delivery systems responsive to the physical environment
DE69113847T2 (de) Injektionsspritze mit angezeigter Dosierung.
AT72991T (de) Nasale verabreichung von arzneimitteln.
DE69901570D1 (de) Ranolazinhaltige arzneimittel mit verzögerter wirkstoffabgabe
DE69122863D1 (de) Geschlossenes arzneimittelabgabesystem
EG19770A (en) Device for the administration of powdered medicinal substances
DE59309635D1 (de) Topische Arzneiformen mit Insulin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties